Have a feature idea you'd love to see implemented? Let us know!

AMED Amedisys Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMED

Price (delayed)

$97.33

Market cap

$3.19B

P/E Ratio

34.51

Dividend/share

N/A

EPS

$2.82

Enterprise value

$3.5B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The P/E is 76% below the 5-year quarterly average of 145.1
The quick ratio has increased by 27% YoY and by 8% QoQ
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.amedisys.com
Peers: CHE NHC ADUS CIVI

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.74M
Market cap
$3.19B
Enterprise value
$3.5B
Valuations
Price to earnings (P/E)
34.51
Price to book (P/B)
2.83
Price to sales (P/S)
1.39
EV/EBIT
19.9
EV/EBITDA
14.93
EV/Sales
1.53
Earnings
Revenue
$2.29B
EBIT
$176.05M
EBITDA
$234.63M
Free cash flow
$89.34M
Per share
EPS
$2.82
Free cash flow per share
$2.73
Book value per share
$34.43
Revenue per share
$70.01
TBVPS
$23.6
Balance sheet
Total assets
$2.12B
Total liabilities
$938.48M
Debt
$474.64M
Equity
$1.13B
Working capital
$75.93M
Liquidity
Debt to equity
0.42
Current ratio
1.16
Quick ratio
1.07
Net debt/EBITDA
1.35
Margins
EBITDA margin
10.2%
Gross margin
44%
Net margin
4%
Operating margin
7%
Efficiency
Return on assets
4.4%
Return on equity
8.5%
Return on invested capital
29.1%
Return on capital employed
10.8%
Return on sales
7.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
0.29%
1 week
0.92%
1 month
0.47%
1 year
5.55%
YTD
2.39%
QTD
0.85%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.29B
Gross profit
$1.01B
Operating income
$160.05M
Net income
$91.98M
Gross margin
44%
Net margin
4%
AMED's operating income is up by 10% since the previous quarter but it is down by 4.9% year-on-year
The company's operating margin fell by 8% YoY but it rose by 8% QoQ
AMED's gross profit is up by 3.1% year-on-year
Amedisys's revenue has increased by 2.7% YoY

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
AMED P/E details
P/E
34.51
P/B
2.83
P/S
1.39
EV/EBIT
19.9
EV/EBITDA
14.93
EV/Sales
1.53
The P/E is 76% below the 5-year quarterly average of 145.1
The P/B is 51% less than the 5-year quarterly average of 5.8
AMED's equity is up by 12% year-on-year and by 3.4% since the previous quarter
The P/S is 40% less than the 5-year quarterly average of 2.3
Amedisys's revenue has increased by 2.7% YoY

Efficiency

How efficient is Amedisys business performance
AMED's ROS has soared by 166% from the previous quarter and by 126% YoY
The ROIC has soared by 165% from the previous quarter and by 160% YoY

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 126% higher than its total liabilities
The quick ratio has increased by 27% YoY and by 8% QoQ
The current ratio has increased by 26% YoY and by 6% QoQ
The company's debt is 58% lower than its equity
The debt to equity has contracted by 13% YoY and by 4.5% from the previous quarter
AMED's equity is up by 12% year-on-year and by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.